AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Case Report: Successful Rechallenge With Cisplatin Following Cisplatin Induced Ischemic Cerebrovascular Accident In A Patient with Small Cell Lung Cancer.
  • +2
  • Farah Rahat,
  • Nabil Omar,
  • Hassan Aakel,
  • Ussama Al-Homsi,
  • Alaaeldin Shablak
Farah Rahat
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
Nabil Omar
Hamad Medical Corporation
Author Profile
Hassan Aakel
Hamad Medical Corporation
Author Profile
Ussama Al-Homsi
Hamad Medical Corp
Author Profile
Alaaeldin Shablak
Hamad Medical Corporation
Author Profile

Abstract

Cisplatin is a widely used platinum-based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have Small-cell Lung Cancer who developed ischemic cerebrovascular accident (CVA) after receiving chemotherapy regimen including cisplatin.

Peer review status:ACCEPTED

16 May 2022Submitted to Clinical Case Reports
Show details
Hide details
16 May 2022Submission Checks Completed
16 May 2022Assigned to Editor
10 Aug 2022Reviewer(s) Assigned
16 Aug 2022Review(s) Completed, Editorial Evaluation Pending
19 Aug 2022Editorial Decision: Revise Minor
13 Sep 20221st Revision Received
14 Sep 2022Submission Checks Completed
14 Sep 2022Assigned to Editor
14 Sep 2022Review(s) Completed, Editorial Evaluation Pending
30 Sep 2022Editorial Decision: Accept